Currently out of the existing stock ratings of Jessica Tassan, 20 are a HOLD (25.32%), 4 are a SELL (5.06%), 55 are a BUY (69.62%).

Jessica Tassan

Work Performance Price Targets & Ratings Chart

Analyst Jessica Tassan works at PIPER SANDLER with a stock forecast success ratio of 38.9% fulfilled within 40.1 days on average.

Jessica Tassan’s has documented 169 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HCAT, Health Catalyst at 23-Feb-2024.

Wall Street Analyst Jessica Tassan

Analyst best performing recommendations are on ACCD (ACCOLADE ).
The best stock recommendation documented was for HCAT (HEALTH CATALYST) at 9/13/2022. The price target of $11 was fulfilled within 1 day with a profit of $0.28 (2.61%) receiving and performance score of 26.12.

Average potential price target upside

of $8.23 (15.35%) on OMCL (OMNICELL).
of $8.19 (37.61%) on PHR (PHREESIA).
of $6.06 (23.83%) on EVH (EVOLENT HEALTH).

CANO Cano Health CMAX CareMax HCAT Health Catalyst SGFY Signify Health TRHC Tabula Rasa HealthCare CHNG Change Healthcare EVH Evolent Health OMCL Omnicell OSH Oak Street Health PHR Phreesia TDOC Teladoc ALHC Alignment Healthcare LLC PRVA Privia Health Group AMWL American Well Corp DOCS Doximity MDRX Allscripts Healthcare Solutions ACCD Accolade CVS CVS Health Corp NXGN Nextgen Healthcare PINC Premier UNH UnitedHealth Group orporated

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Andrew Mok (UBS)